title: The concept and practice of Fanconi Anemia: from the clinical bedside to the laboratory bench.
abstract: Fanconi Anemia (FA) is characterised with multiple gene mutations, multiple types of genetic abnormalities, multiple organ involvements and multiple types of cancer risks. It is a life threatening disease commonly at 5 years old children. Research on FA is one of the fastest areas in medical research field. The identification of 15 different FA genes and the elucidation of the FA molecular pathways have translated into the understanding of the pathogenic mechanism and practically provided the directions for therapies. Studies on FA rendered invaluable information for the studies on cancers because FA possesses the unique features in many different biological aspects. Studies revealed the genetic linking between FA and cancers that FA genes are in cancers and cancers genes are in FA. As a result, FA is named as a paradigmatic disease for the understanding of cancer and aging. In clinical practice, an early and accurate diagnosis of FA before the stage of bone marrow failure, cancer/leukemia is crucial for the adequate treatment, the prevention of serious medical complications and also for the properly management in the other caring areas including paediatric, hematology, immunology, endocrinology, reproductive/IVF, obstetrics and surgery. However, an early and accurate diagnosis for FA is often difficult because FA is genetically and phenotypically heterogeneous disease. Diagnosis in more or less cases can be delayed until bone marrow failure or cancer/leukemia occurs. As a result that delayed or misdiagnosis even wrong treatment received for patients with FA are not uncommon events clinically in some regions or countries due to the lack of recognition of FA from the clinicians and the limitation in testing resource in laboratory. In this review, the new concept, brief clinical characteristics, research advancing, diagnostic guidelines/differential diagnosis, laboratory testing issues and strategies on FA are discussed.
authors.affiliation: Western Sydney Genomics, Western Sydney Genetic Program, The Children's Hospital at Westmead, NSW, Australia.
authors.forename: Zhan-He
authors.initials: ZH
authors.lastname: Wu
keywords: Fanconi Anemia testing; autosomal recessive disease; bone marrow failure syndromes; cancer susceptibility; chromosomal instability syndromes
references.citation: Anemia. 2012;2012:926787
references.pmid: 22675617
references.citation: Proc Natl Acad Sci U S A. 2001 May 8;98(10):5734-9
references.pmid: 11344308
references.citation: Br J Haematol. 2010 Jul;150(2):179-88
references.pmid: 20507306
references.citation: Anemia. 2012;2012:238731
references.pmid: 22693659
references.citation: Nat Genet. 2004 Nov;36(11):1219-24
references.pmid: 15502827
references.citation: Blood Rev. 2010 May;24(3):101-22
references.pmid: 20417588
references.citation: Blood. 1996 May 15;87(10):4424-32
references.pmid: 8639804
references.citation: Blood. 2003 May 15;101(10):3872-4
references.pmid: 12511406
references.citation: Blood. 2000 Feb 15;95(4):1493-8
references.pmid: 10666230
references.citation: Pediatrics. 2001 Apr;107(4):744-54
references.pmid: 11335753
references.citation: Cancer Genet Cytogenet. 1991 Jan;51(1):1-12
references.pmid: 1984836
references.citation: Best Pract Res Clin Haematol. 2001 Sep;14(3):631-44
references.pmid: 11640873
references.citation: Schweiz Med Wochenschr. 1965 Oct 23;95(43):1461-4
references.pmid: 5880935
references.citation: Pediatrics. 1981 Jan;67(1):119-27
references.pmid: 7243420
references.citation: Mutat Res. 2009 Jul 31;668(1-2):4-10
references.pmid: 19622403
references.citation: Blood. 1989 Feb;73(2):391-6
references.pmid: 2917181
references.citation: Mol Med. 1998 Jul;4(7):468-79
references.pmid: 9713825
references.citation: Cancer. 2003 Jan 15;97(2):425-40
references.pmid: 12518367
references.citation: Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2532-7
references.pmid: 11226273
references.citation: Am J Med. 1991 Nov;91(5):555-7
references.pmid: 1951421
references.citation: Mol Ther. 2005 Nov;12(5):976-84
references.pmid: 16084127
references.citation: Semin Hematol. 1967 Jul;4(3):233-40
references.pmid: 6074578
references.citation: Haematologica. 2008 Apr;93(4):511-7
references.pmid: 18322251
references.citation: Am J Med Genet A. 2011 Aug;155A(8):1877-83
references.pmid: 21739583
references.citation: Anemia. 2012;2012:132856
references.pmid: 22720145
references.citation: Science. 2002 Jul 26;297(5581):606-9
references.pmid: 12065746
references.citation: J Med Genet. 2011 Apr;48(4):242-50
references.pmid: 21217111
references.citation: Exp Hematol. 1993 Jun;21(6):731-3
references.pmid: 8500573
references.citation: Blood. 2000 Dec 15;96(13):4064-70
references.pmid: 11110674
references.citation: Nat Genet. 1992 Jun;1(3):196-8
references.pmid: 1303234
references.citation: Blood. 1994 Sep 1;84(5):1650-5
references.pmid: 8068955
references.citation: Pediatrics. 1993 Jun;91(6):1116-20
references.pmid: 8502512
references.citation: Br Med Bull. 2006;77-78:37-53
references.pmid: 16968690
references.citation: Blood. 2011 Apr 14;117(15):e161-70
references.pmid: 21325596
references.citation: J Med Genet. 2003 Jan;40(1):1-10
references.pmid: 12525534
references.citation: Curr Biol. 2009 Mar 24;19(6):524-9
references.pmid: 19268590
references.citation: Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7155-60
references.pmid: 19369211
references.citation: Blood. 2003 Feb 1;101(3):822-6
references.pmid: 12393424